Cargando…
Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis
To counteract the deadly pathogens, i.e., Y. pestis, Y. enetrocolitica, and Y. pseudotuberculosis, we prepared a recombinant DNA construct lcrV-hsp70 encoding the bivalent fusion protein LcrV-HSP70. The lcrV gene of Y. pestis and hsp70 domain II DNA fragment of M. tuberculosis were amplified by PCR....
Autores principales: | Gupta, Ankit, Narayan, Bineet, Kumar, Subodh, Verma, Shailendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303293/ https://www.ncbi.nlm.nih.gov/pubmed/32595634 http://dx.doi.org/10.3389/fimmu.2020.00988 |
Ejemplares similares
-
A Recombinant Trivalent Fusion Protein F1–LcrV–HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis
por: Verma, Shailendra K., et al.
Publicado: (2016) -
Glutathionylation of Yersinia pestis LcrV and Its Effects on Plague Pathogenesis
por: Mitchell, Anthony, et al.
Publicado: (2017) -
HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model
por: Batra, Lalit, et al.
Publicado: (2014) -
Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine
por: Li, Wei, et al.
Publicado: (2013) -
Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model
por: Daniel, Catherine, et al.
Publicado: (2019)